Explore the emerging role of psychedelics in pharmacy practice and their potential to transform mental health treatment. This episode dives into the science, safety, and regulatory considerations pharmacists need to know as these therapies move toward mainstream use. Don’t miss this opportunity to stay ahead of the curve—tune in and expand your understanding of this groundbreaking area of care!

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Colby Burns, PharmD
Clinical Pharmacist, CHAS Healthcare
President, Psychedelic Pharmacist Association
Owner/Host, Neural Pharm Online Platform and Podcast

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the current evidence and therapeutic potential of psychedelics in treating mental health conditions.
2. Identify key safety, regulatory, and clinical considerations for pharmacists as psychedelics become integrated into patient care.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-023-H01-P
Initial release date: 1/13/2025
Expiration date: 1/13/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram